Ruxolitinib Cream for Vitiligo in Pakistan—Well Mart

Ruxolitinib cream is a topical JAK inhibitor approved for treating non-segmental vitiligo. It helps repigment skin by reducing immune-driven inflammation and promoting melanocyte regeneration.

Ingredients:

Benefits:

• Promotes repigmentation by reducing inflammation that hinders melanocyte activity.
• Effective for facial and non-facial vitiligo, particularly in early stages.
• Provides a non-invasive treatment option.
• FDA-approved, ensuring clinical efficacy and safety.

How to Use:

• Apply a thin layer of Ruxolitinib cream to depigmented areas twice daily, as directed by your healthcare provider.
• Avoid applying on broken or infected skin.
• Wash hands before and after application unless treating hands.
• Results typically appear after 24 weeks, with significant improvements over time.
• Protect treated areas from excessive sun exposure, using sunscreen as needed.